Shareholder Alert: Ademi LLP investigates whether Satsuma Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Shin Nippon

Provided By PR Newswire

Last update: May 1, 2023

MILWAUKEE, May 1, 2023 /PRNewswire/ -- Ademi LLP is investigating Satsuma (NASDAQ: STSA) for possible breaches of fiduciary duty and other violations of law in its transaction with Shin Nippon.